Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • IREN vs GSK✓SelectedUSD · GSKIREN vs GSK performance historyLatest closeAs of-5.45%11/19
Stock and ETF performance explorer

IREN vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+390.1%
GSK return
+53.5%
Excess return
+336.6%
Maximum drawdown
-81.1%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-5.4%-1.6%-3.9%-6.1%
7D-26.0%-4.7%-21.3%-27.7%
30D-45.9%-4.7%-41.2%-46.7%
3M-66.4%-8.8%-57.6%-67.2%
6M-69.8%-4.6%-65.2%-69.8%
YTD-61.8%+1.0%-62.8%-60.7%
1Y-68.6%+6.9%-75.4%-67.1%
All+390.1%+53.5%+336.6%+367.2%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling